World Health Care Leaders With Australian Harrison.AI
Cutting edge health tech
EVIDENCE & insights
Welcome to a place where imagination overcomes impossible.
Franklin.ai is a joint venture between global medical diagnostic leader Sonic Healthcare and Harrison.ai. Combining our skills and experience is the fastest way to achieve our common goal of improving the capacity and quality of pathology services globally.
We’re working hand-in-hand with pathologists to develop AI-powered tools that will augment their pivotal role at the heart of the healthcare system. Our mission is to put groundbreaking artificial intelligence in the hands of pathologists globally, and benefit millions of patients.
Harrison.ai is a global healthcare technology company on a mission to urgently scale healthcare capacity through AI-powered medical imaging diagnostic support and workflow solutions. Our radiology and pathology solutions help clinicians deliver faster, more accurate diagnoses, aiding in the early detection of cancer and other medical conditions.
And a thirst for knowledge meets a passion for a passion for a better world.
A world where people are cared for by people, medical data analysis is done at scale, autonomously using AI, and anyone can get the right care at the right time.
Why do we need this?
One of the biggest problems we’re facing this century is the inequality and capacity of the healthcare system. Capacity in many areas of clinical diagnosis and treatment are under strain due to ongoing increases in healthcare demand combined with skills shortages.
So, what is HARRISON.AI doing to help?
We’re using state-of-the-art AI and partnering with healthcare specialists, to create best-in-class AI diagnostic support solutions to help solve healthcare capacity challenges.
A world where people are cared for by people, medical data analysis is done at scale, autonomously using AI, and anyone can get the right care at the right time.
Why do we need this?
One of the biggest problems we’re facing this century is the inequality and capacity of the healthcare system. Capacity in many areas of clinical diagnosis and treatment are under strain due to ongoing increases in healthcare demand combined with skills shortages.
So, what is HARRISON.AI doing to help?
We’re using state-of-the-art AI and partnering with healthcare specialists, to create best-in-class AI diagnostic support solutions to help solve healthcare capacity challenges.
Harrison.ai and I-MED Radiology, the third largest private network of radiology clinics in the world, partnered in 2020 to create comprehensive radiology AI solutions. The first solution, Annalise Enterprise CXR is one of the world’s most comprehensive AI clinical decision-support solutions for chest X-rays and can identify up to 124 findings. Annalise Enterprise CXR was developed and commercialised within 18 months and was followed by the release of another cutting edge comprehensive decision-support AI solution for non-contrast head CT images. Annalise.ai solutions are already available to 50% of radiologists in Australia and clinics in APAC, Europe, UK, Middle-East and the US.
Franklin.ai is a joint venture between global medical diagnostic leader Sonic Healthcare and Harrison.ai. Combining our skills and experience is the fastest way to achieve our common goal of improving the capacity and quality of pathology services globally.
We’re working hand-in-hand with pathologists to develop AI-powered tools that will augment their pivotal role at the heart of the healthcare system. Our mission is to put groundbreaking artificial intelligence in the hands of pathologists globally, and benefit millions of patients.
Founded by brothers Dimitry and Aengus Tran, Harrison.ai has built its own large language model for reading X-rays and CT scans that supports the detection and diagnosis of medical conditions – including cancer – quickly and accurately.
The technology significantly increases the number of treatable cases and the survivability of patients, with the software currently used in more than 1,000 healthcare facilities worldwide.
The technology significantly increases the number of treatable cases and the survivability of patients, with the software currently used in more than 1,000 healthcare facilities worldwide.
“There is currently a severe global shortage of radiologists and pathologists, resulting in significant diagnostic delays that can have life-threatening consequences for patients,” Mr Wilder said.
“Harrison.ai’s technology provides medical professionals with a powerful tool to detect and diagnose medical conditions quickly and accurately, alleviating pain and saving lives.
“The funding will also allow Harrison.ai to continue expanding its services into other hospitals and healthcare facilities in Australia and around the world.”
Harrison.ai co-CEO Aengus Tran said Australia had the potential to take a global lead in clinical AI and that the investment would let the company accelerate the roll-out of its products across Australia and internationally.
The Harrison.ai investment is the latest in what has been a busy summer for the National Reconstruction Fund and follows the $100 million allocated in December with significant placements in companies like IoT specialist Myriota, quantum processor leader Quantum Brilliance and secure data operations outfit Vault Cloud.
“Harrison.ai’s technology provides medical professionals with a powerful tool to detect and diagnose medical conditions quickly and accurately, alleviating pain and saving lives.
“The funding will also allow Harrison.ai to continue expanding its services into other hospitals and healthcare facilities in Australia and around the world.”
Harrison.ai co-CEO Aengus Tran said Australia had the potential to take a global lead in clinical AI and that the investment would let the company accelerate the roll-out of its products across Australia and internationally.
The Harrison.ai investment is the latest in what has been a busy summer for the National Reconstruction Fund and follows the $100 million allocated in December with significant placements in companies like IoT specialist Myriota, quantum processor leader Quantum Brilliance and secure data operations outfit Vault Cloud.
Press Release on Series C Funding Round
LEADING GLOBAL HEALTHTECH COMPANY, HARRISON.AI, TO BRING PROVEN AI-POWERED MEDICAL DIAGNOSTIC SUPPORT AND WORKFLOW SOLUTIONS TO THE UNITED STATES; US$112 MILLION SERIES C FUELS GLOBAL EXPANSION
Company’s Radiology and Pathology Solutions Expand Clinician Capacity, Increase Operational Efficiency, and Improve Early Disease Diagnosis
Boston, Massachusetts – February 11, 2025 – Harrison.ai, a leading global healthtech company and developer of AI-powered medical diagnostic support and workflow solutions, announced today the accelerated expansion of its operations into the United States, a move supported by US$112 million of Series C funding. The funding will also fuel the company’s product roadmap and continued growth in the UK, EMEA and APAC. The round is one of the largest capital raises in the medical AI space over the past twelve months.
The round was co-led by Aware Super, ECP and existing investor, Horizons Ventures. New investors, such as Australia’s National Reconstruction Fund Corporation (NRFC), Ord Minnett and Wollemi Capital Group also participated, along with existing investors including Blackbird Ventures and Alpha JWC Ventures. Harrison.ai’s total capital raised to date exceeds US$240 million.
Harrison’s technology in radiology and pathology assists clinicians with identifying signs of cancer and other critical illnesses earlier, improving treatment decisions and patient outcomes.
It uses AI to analyze CT scans, X-rays, and pathology slides, supporting clinicians in detecting and diagnosing medical conditions faster and more accurately.
Harrison.ai aims to address the global shortage of 1.5 million skilled clinicians and the surge in demand for diagnosis impacting both developed and under-developed healthcare systems. In the United States, according to a study by the Association of American Medical Colleges, there are 11 radiologists per 100,000 people. More than two-thirds of the world’s pathologists are distributed across only 10 countries.
“The growing demand for equitable and effective healthcare calls for advanced systems like AI to enhance human diagnostics and address disparities in access to care,” said Dr. Aengus Tran, Harrison.ai Co-Founder and Chief Executive Officer.
“Harrison.ai meets this need by developing clinical-grade AI models designed to improve capacity.
We look forward to bringing our life-saving technology to healthcare systems in the U.S. and continuing our expansion across the globe.”
“Harrison.ai’s ability to harness the rapidly evolving opportunities out of digitization and AI is remarkable and we look forward to supporting their long-term application to the healthcare sector,” said Alvin Chan, Portfolio Manager – Direct Equities at Aware Super, one of Australia’s largest pension funds managing A$190 billion on behalf of its 1.15 million members.
Harrison.ai solutions are driving a significant improvement through early lung cancer detection within hospital systems. Radiologists using Harrison.ai’s technology have seen an over 45% increase in diagnostic accuracy
1. Studies indicate that Harrison’s AI for chest radiography can aid in the early detection of lung cancer, showing that over 32% of lung cancer cases could have been diagnosed sooner—by an average of 16 months
2. Additionally, it has been shown to enhance clinical outcomes by increasing the proportion of cases detected at treatable stages by more than 26%
3.Over 1,000 healthcare facilities worldwide support the care of more than six million patients each year with Harrison.ai solutions. Its radiology solution (Annalise.ai) is available to 1 in 2 radiologists in Australia, and processes scans for more than 45 Trusts and over 131 public hospitals in the United Kingdom, including 35% of chest X-ray volume in England. It also powers all CT Brain scans across public accident and emergency (A&E) systems in Hong Kong and was recently selected by the Danish public healthcare system to help clinicians deliver better outcomes.
Further accelerating its global commercialization efforts, Harrison.ai is establishing a North American presence in Boston. The company will focus on building its U.S. operations and growing the Harrison.ai customer base. The company has already received 12 FDA clearances, and one of its CT Brain algorithms has FDA Breakthrough Device Designation and Medicare reimbursement through the New Technology Add-on Payment (NTAP).
Harrison.rad.1, its radiology-specific vision-language technology was developed last year and is now accessible to researchers, industry partners, regulators, and others in the AI community.
Harrison.ai was invited to participate in the Healthcare AI Challenge hosted by Mass General Brigham, where it joins Microsoft, OpenAI, Google, and others in a series of events to assess AI technology and generate insights from healthcare professional participants. This initiative is intended to help inform the community and industry to ensure adherence to high standards for efficacy and safety for AI in medical imaging and healthcare more broadly.
About Harrison.ai
Harrison.ai is a global healthcare technology company on a mission to urgently scale healthcare capacity through AI-powered medical imaging diagnostic support and workflow solutions. Its radiology (Annalise.ai) and pathology (Franklin.ai) solutions help clinicians deliver faster, more accurate diagnoses, aiding in the early detection of cancer and other medical conditions. Harrison.ai partners with hospitals and private clinics across APAC, EMEA, the United Kingdom and United States. For more information, visit Harrison.ai.
Media Contacts
Sling & Stone
harrison@slingstone.com
Further accelerating its global commercialization efforts, Harrison.ai is establishing a North American presence in Boston. The company will focus on building its U.S. operations and growing the Harrison.ai customer base. The company has already received 12 FDA clearances, and one of its CT Brain algorithms has FDA Breakthrough Device Designation and Medicare reimbursement through the New Technology Add-on Payment (NTAP).
Harrison.rad.1, its radiology-specific vision-language technology was developed last year and is now accessible to researchers, industry partners, regulators, and others in the AI community.
Harrison.ai was invited to participate in the Healthcare AI Challenge hosted by Mass General Brigham, where it joins Microsoft, OpenAI, Google, and others in a series of events to assess AI technology and generate insights from healthcare professional participants. This initiative is intended to help inform the community and industry to ensure adherence to high standards for efficacy and safety for AI in medical imaging and healthcare more broadly.
About Harrison.ai
Harrison.ai is a global healthcare technology company on a mission to urgently scale healthcare capacity through AI-powered medical imaging diagnostic support and workflow solutions. Its radiology (Annalise.ai) and pathology (Franklin.ai) solutions help clinicians deliver faster, more accurate diagnoses, aiding in the early detection of cancer and other medical conditions. Harrison.ai partners with hospitals and private clinics across APAC, EMEA, the United Kingdom and United States. For more information, visit Harrison.ai.
Media Contacts
Sling & Stone
harrison@slingstone.com
Join us for Millions Moments, highlighting the most insightful and memorable moments from Millions season one.
In our final Millions Moments episode of season one, we are revisiting our chat with Mikiko Bazeley.
This episode covers the journey of Machine Learning from 2013, breaking down the three main stages of the Machine Learning process and the pros and cons of being in the Renaissance period of ML projects and products.
To hear more, check out the full episode titled “Featureform: to move the world forward, we need to keep our minds open-source.”
Welcome to the Millions: AI Transforming Business podcast where we bring you insightful conversations with the brightest minds in the industry. Join us as we sit down with top engineers, data scientists, and innovators from leading tech companies to explore the profound impact of AI, not only as a transformative power in the business landscape but also in reshaping the world around us.
Millions is brought to you by Harrison.ai, a cutting edge healthtech company that's on a mission to urgently scale global healthcare capacity, using AI automation to elevate the care clinicians can provide.
So WHO exactly is Dr Aengus Tran,
CEO and Founder of Harrison AI?
> Co-founder, harrison.ai, annalise.ai & franklin.ai
> Doctor of Medicine (MD)
> Al engineer and data scientist
> Daily Telegraph’s Top30 Tech Entrepreneurs under 30
> Forbes 30 under 30 in Asia
> Doctor of Medicine (MD)
> Al engineer and data scientist
> Daily Telegraph’s Top30 Tech Entrepreneurs under 30
> Forbes 30 under 30 in Asia
"When Aengus and Dimitry Tran were growing up in Ho Chi Minh City, one of the family’s most treasured possessions was a computer. Sent to their father by an uncle who lived in France, it was one of the first computers in Vietnam. Their parents were high school maths teachers and, armed with this new possession, their father taught himself programming.
“He wrote the first programming book in Vietnamese, ever,” Dimitry tells The Australian Financial Review Magazine. “In our office, there’s a photo of my mum with Aengus as a baby next to our precious family computer – one of the most valuable things we had as a family.” via AFR
